I would like more information about Tretten®
Manny has congenital factor XIII deficiency
Tretten® is the only recombinant therapy for congenital factor XIII A-subunit deficiency, a bleeding disorder affecting about 1 in every 1 to 3 million people
I would like assistance with getting and using Tretten®
I would like to talk to a Novo Nordisk Rare Blood Community Liaison (RBCL)